title: Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer.
abstract: This paper provides an overview of cancer management, particularly with respect to colorectal cancer (CRC), in Germany. The information presented reflects findings from the peer-review literature and government documentation, as well as interviews with cancer and CRC specialists. Topics such as epidemiology, expenditure, CRC screening, pharmaceutical and non-pharmaceutical treatment are discussed in this paper. Furthermore, insights into the German reimbursement system with regard to cancer management as well as regulatory aspects are presented.
authors.affiliation: Leibniz University Hannover, Hannover, Germany. jms@ivbl.uni-hannover.de
authors.forename: J-Matthias
authors.initials: JM
authors.lastname: von der Schulenburg
authors.forename: Anne
authors.initials: A
authors.lastname: Prenzler
authors.forename: Willemien
authors.initials: W
authors.lastname: Schurer
mesh_terms: D000328:Adult; D000368:Aged; D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000191:economics* / Q000453:epidemiology / Q000628:therapy; D003953:Diagnosis-Related Groups; D005260:Female; D005858:Germany / Q000453:epidemiology; D006291:Health Policy; D006801:Humans; D007348:Insurance, Health; D007407:Interviews as Topic; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D012042:Registries; D012051:Reimbursement Mechanisms; D012196:Review Literature as Topic